Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-070920
Filing Date
2025-07-25
Accepted
2025-07-25 18:54:18
Documents
1
Period of Report
2025-07-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2521564-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2521564-1_4seq1.xml 4 4648
  Complete submission text file 0001104659-25-070920.txt   6742
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Issuer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address SVEAVAGEN 17 18TH FLOOR STOCKHOLM V7 SE-11157
Business Address SVEAVAGEN 17 18TH FLOOR STOCKHOLM V7 SE-11157 46705142196
TRILL AB (Reporting) CIK: 0001887436 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36291 | Film No.: 251152727

Mailing Address C/O TRILL INVEST AB SVEAVAGEN 17 FL 18 STOCKHOLM V7 SE 111 57
Business Address
STAHLBERG JAN (Reporting) CIK: 0001983161 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36291 | Film No.: 251152728